|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.72 HKD | +0.74% |
|
+4.21% | -27.08% |
Luye Pharma Group Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 2,904.11 million compared to CNY 2,850.83 million a year ago. Net income was CNY 149.98 million compared to CNY 297 million a year ago.
Basic earnings per share from continuing operations was CNY 0.0406 compared to CNY 0.0854 a year ago. Diluted earnings per share from continuing operations was CNY 0.0406 compared to CNY 0.0854 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -27.08% | 1.31B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
LUYE PHARMA GROUP LTD. 
